Real-time enrollment status for this ectonucleotide pyrophosphatase/phosphodiesterase1 deficiency clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:24 PM UTC
| NCT Number | NCT05734196 |
| Recruiting Status | Recruiting |
| Condition | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 16 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Inozyme Pharma |
| Last Updated on CT.gov | March 24, 2026 (Mar 24, 2026) |
As of July 13, 2026: Clinical trial NCT05734196 is currently recruiting participants. This clinical trial study for ectonucleotide pyrophosphatase/phosphodiesterase1 deficiency is actively seeking new participants at 5 locations across the United States. The study is sponsored by Inozyme Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05734196 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05734196 was last updated Mar 24, 2026 (March 24, 2026). HelloStudys verifies this status automatically.